TrialDiabetologia2015
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study.
Kwok-Leung Ong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled ittrialcites it